• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子健康干预措施对非酒精性脂肪性肝病患者生活方式改变的效果:系统评价和荟萃分析。

The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.

机构信息

College of Nursing and Brain Korea 21 FOUR Project, Yonsei University, Seoul, Republic of Korea.

College of Nursing, Yonsei University, Seoul, Republic of Korea.

出版信息

J Med Internet Res. 2023 Jan 23;25:e37487. doi: 10.2196/37487.

DOI:10.2196/37487
PMID:36689264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9903182/
Abstract

BACKGROUND

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing in parallel with the epidemic of obesity and metabolic syndrome. Lifestyle modification is a crucial strategy for the treatment of NAFLD, which can lead to a reduction in liver fat with concomitant weight loss. The use of eHealth technologies is an effective approach to improve health outcomes in patients as they do not have any time and space limitations.

OBJECTIVE

This study aimed to evaluate published eHealth intervention studies for the improvement of lifestyle modifications among patients with NAFLD and to provide recommendations for future studies.

METHODS

We conducted a systematic review and meta-analysis. Five electronic databases (PubMed, Cochrane Central, CINAHL, Embase, and Web of Science) were searched for studies reporting the effect of lifestyle modification intervention using eHealth in patients with NAFLD published from inception to November 3, 2022. Study selection, data extraction, and quality assessment were performed by 3 researchers independently. The quality of included studies was assessed using the Cochrane risk of bias tool and the Risk of Bias Assessment Tool for Nonrandomized Studies.

RESULTS

In total, 2688 records were identified, and 41 full-text articles were assessed. Seven studies were included in the systematic review. The participants of all interventions were 1257 individuals with NAFLD, and the mean age ranged from 38.3 to 57.9 years. The duration of the interventions was 3-24 months, and all interventions were categorized into 3 types: internet-based computers, telephones, and mobile apps. Of these, 4 studies were randomized controlled trials and were included in the meta-analysis: 3 studies for body weight and BMI and 4 studies for alanine aminotransferase (ALT) and aspartate aminotransferase (AST). According to the meta-analysis, clear improvements in BMI (P=.02; 95% CI -1.01 to -0.10), AST (P=.02; 95% CI -1.22 to -0.13), and ALT (P=.01; 95% CI -1.28 to -0.15) were observed in the eHealth intervention as compared with the control groups.

CONCLUSIONS

Lifestyle modification interventions using eHealth technologies are significantly effective for BMI, AST, and ALT in patients with NAFLD. Future research should conduct interventions with larger sample sizes and evaluate whether these interventions have sustained benefits, and how we can make these eHealth methods most effective on a large scale.

摘要

背景

非酒精性脂肪性肝病(NAFLD)的患病率与肥胖症和代谢综合征的流行呈平行上升趋势。生活方式改变是治疗 NAFLD 的关键策略,可导致肝脂肪减少和体重减轻。使用电子健康技术是改善患者健康结果的有效方法,因为它们没有任何时间和空间限制。

目的

本研究旨在评估已发表的使用电子健康技术改善 NAFLD 患者生活方式改变的干预研究,并为未来的研究提供建议。

方法

我们进行了系统评价和荟萃分析。从成立到 2022 年 11 月 3 日,我们在五个电子数据库(PubMed、Cochrane 中央、CINAHL、Embase 和 Web of Science)中搜索了报告使用电子健康技术改善 NAFLD 患者生活方式改变的干预研究。由 3 名研究人员独立进行研究选择、数据提取和质量评估。使用 Cochrane 偏倚风险工具和非随机研究偏倚风险评估工具评估纳入研究的质量。

结果

共确定了 2688 条记录,评估了 41 篇全文文章。有 7 项研究纳入了系统评价。所有干预措施的参与者均为 1257 名 NAFLD 患者,平均年龄为 38.3 至 57.9 岁。干预持续时间为 3-24 个月,所有干预措施均分为 3 种类型:基于互联网的计算机、电话和移动应用程序。其中,4 项研究为随机对照试验,并纳入了荟萃分析:3 项研究用于体重和 BMI,4 项研究用于丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)。根据荟萃分析,与对照组相比,电子健康干预组 BMI(P=.02;95%CI -1.01 至 -0.10)、AST(P=.02;95%CI -1.22 至 -0.13)和 ALT(P=.01;95%CI -1.28 至 -0.15)的改善更为明显。

结论

使用电子健康技术的生活方式改变干预措施对 NAFLD 患者的 BMI、AST 和 ALT 非常有效。未来的研究应该进行更大样本量的干预,并评估这些干预措施是否具有持续的益处,以及我们如何在大规模上使这些电子健康方法最有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/2c41cd8b598f/jmir_v25i1e37487_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/45580de96ad8/jmir_v25i1e37487_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/bde3ffc7c687/jmir_v25i1e37487_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/9b1f6d732670/jmir_v25i1e37487_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/d5199039209c/jmir_v25i1e37487_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/fbb4b7a495e0/jmir_v25i1e37487_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/a552aa88a086/jmir_v25i1e37487_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/2c41cd8b598f/jmir_v25i1e37487_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/45580de96ad8/jmir_v25i1e37487_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/bde3ffc7c687/jmir_v25i1e37487_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/9b1f6d732670/jmir_v25i1e37487_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/d5199039209c/jmir_v25i1e37487_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/fbb4b7a495e0/jmir_v25i1e37487_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/a552aa88a086/jmir_v25i1e37487_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/9903182/2c41cd8b598f/jmir_v25i1e37487_fig7.jpg

相似文献

1
The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.电子健康干预措施对非酒精性脂肪性肝病患者生活方式改变的效果:系统评价和荟萃分析。
J Med Internet Res. 2023 Jan 23;25:e37487. doi: 10.2196/37487.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的生活方式干预:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jun 11;6(6):CD013156. doi: 10.1002/14651858.CD013156.pub2.
6
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
7
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充:一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.
8
Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury.脑损伤儿童和青少年记忆与执行功能康复的技术辅助手段。
Cochrane Database Syst Rev. 2016 Jul 1;7(7):CD011020. doi: 10.1002/14651858.CD011020.pub2.
9
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.
10
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.

引用本文的文献

1
Managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Digital Era: Overcoming Barriers to Lifestyle Change.数字时代代谢功能障碍相关脂肪性肝病(MASLD)的管理:克服生活方式改变的障碍
Cureus. 2025 May 25;17(5):e84803. doi: 10.7759/cureus.84803. eCollection 2025 May.
2
Challenges and needs in the management of non-alcoholic fatty liver disease from the perspective of gastroenterology and hepatology specialists: a qualitative study.从胃肠病学和肝病学专家角度看非酒精性脂肪性肝病管理中的挑战与需求:一项定性研究
BMC Gastroenterol. 2025 May 22;25(1):396. doi: 10.1186/s12876-025-03921-z.
3
eHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.

本文引用的文献

1
Placebo effect on progression and regression in NASH: Evidence from a meta-analysis.安慰剂效应对 NASH 进展和缓解的影响:来自荟萃分析的证据。
Hepatology. 2022 Jun;75(6):1647-1661. doi: 10.1002/hep.32315. Epub 2022 Jan 24.
2
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD.一项关于MAFLD与NAFLD患病率及危险因素差异的观察性数据荟萃分析。
Clin Gastroenterol Hepatol. 2023 Mar;21(3):619-629.e7. doi: 10.1016/j.cgh.2021.11.038. Epub 2021 Dec 4.
3
A clinical overview of non-alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know.
电子健康干预措施与代谢功能障碍相关脂肪性肝病患者:一项系统评价与荟萃分析
BMJ Open Gastroenterol. 2025 Apr 9;12(1):e001670. doi: 10.1136/bmjgast-2024-001670.
4
Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial).为代谢功能障碍相关脂肪性肝病患者实施一项由护士提供的、基于社区的肝脏筛查和评估项目(LOCATE-NAFLD试验)。
BMC Health Serv Res. 2025 Mar 22;25(1):421. doi: 10.1186/s12913-025-12580-5.
5
The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study.成人人体测量指标与非酒精性脂肪性肝病的关系:一项横断面研究。
Front Nutr. 2025 Jan 7;11:1494497. doi: 10.3389/fnut.2024.1494497. eCollection 2024.
6
Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective.生活方式干预治疗代谢相关脂肪性肝病:24 小时综合行为观点
Hepatol Int. 2024 Oct;18(Suppl 2):959-976. doi: 10.1007/s12072-024-10663-9. Epub 2024 May 8.
7
Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者随机化移动技术生活方式方案的实施。
Sci Rep. 2024 Mar 28;14(1):7452. doi: 10.1038/s41598-024-57722-7.
8
Mobile App-Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.基于移动应用的生活方式干预对非酒精性脂肪性肝病患者的效果:随机对照试验。
J Med Internet Res. 2024 Feb 15;26:e49839. doi: 10.2196/49839.
9
Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial.远程医疗支持的家庭运动计划和饮食建议以增加非酒精性脂肪肝患者植物性蛋白质摄入量:一项为期 12 周的随机对照可行性试验。
Br J Nutr. 2024 May 28;131(10):1709-1719. doi: 10.1017/S0007114524000242. Epub 2024 Jan 25.
10
Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study.代谢综合征与勃起功能障碍:一项系统评价和荟萃分析研究。
J Endocrinol Invest. 2023 Nov;46(11):2195-2211. doi: 10.1007/s40618-023-02136-x. Epub 2023 Jul 29.
非酒精性脂肪性肝病临床概述:诊断指南、临床特征及并发症——非专科医生须知
Diabetes Obes Metab. 2022 Feb;24 Suppl 2:3-14. doi: 10.1111/dom.14521. Epub 2021 Sep 14.
4
Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.基于试点的结构化移动技术的生活方式干预对非酒精性脂肪性肝病患者的影响。
Dig Dis Sci. 2022 Feb;67(2):481-491. doi: 10.1007/s10620-021-06922-6. Epub 2021 May 3.
5
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.更新系统评价报告指南:PRISMA 2020 声明的制定。
J Clin Epidemiol. 2021 Jun;134:103-112. doi: 10.1016/j.jclinepi.2021.02.003. Epub 2021 Feb 9.
6
Effectiveness of Mobile Health Interventions on Diabetes and Obesity Treatment and Management: Systematic Review of Systematic Reviews.移动健康干预措施在糖尿病和肥胖症治疗和管理方面的有效性:系统评价的系统评价。
JMIR Mhealth Uhealth. 2020 Apr 28;8(4):e15400. doi: 10.2196/15400.
7
Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.移动技术辅助生活方式干预对非酒精性脂肪性肝病患者体重减轻的影响:随机对照试验。
JMIR Mhealth Uhealth. 2020 Apr 13;8(4):e14802. doi: 10.2196/14802.
8
Personalised eHealth interventions in adults with overweight and obesity: A systematic review and meta-analysis of randomised controlled trials.成人超重和肥胖的个性化电子健康干预措施:随机对照试验的系统评价和荟萃分析。
Prev Med. 2020 Mar;132:106001. doi: 10.1016/j.ypmed.2020.106001. Epub 2020 Jan 25.
9
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program.基于个体化、基于网络的运动方案改善非酒精性脂肪性肝病的非侵入性标志物。
Aliment Pharmacol Ther. 2019 Oct;50(8):930-939. doi: 10.1111/apt.15427. Epub 2019 Jul 25.
10
A systematic review of tailored eHealth interventions for weight loss.一项针对量身定制的电子健康减肥干预措施的系统评价。
Digit Health. 2019 Feb 5;5:2055207619826685. doi: 10.1177/2055207619826685. eCollection 2019 Jan-Dec.